Status and future perspectives of vaccines for industrialised fin-fish farming

Fish and Shellfish Immunology

Volumn 35, Issue 6, 2013, Pages 1759-1768

  Brudeseth, Bjørn Erik ^a   Wiulsrød, Rune ^a   Fredriksen, Børge Nilsen ^a   Lindmo, Karine ^a   Løkling, Knut Egil ^a   Bordevik, Marianne ^a   Steine, Nils ^a   Klevan, Are ^a   Gravningen, Kjersti ^a  

^a ZOETIS   (United States)

Author keywords

DNA; Emulsion; Fin fish; Licensed vaccine; Live attenuated

Indexed keywords

ARCHOSARGUS RHOMBOIDALIS; DICENTRARCHUS LABRAX; EPINEPHELINAE; EPINEPHELUS SEPTEMFASCIATUS; GADUS MORHUA; HYPEROGLYPHE POROSA; ICTALURUS PUNCTATUS; LATES CALCARIFER; MYSTUS VITTATUS; ONCORHYNCHUS KISUTCH; ONCORHYNCHUS MYKISS; OPLEGNATHUS FASCIATUS; OREOCHROMIS NILOTICUS; PAGRUS MAJOR; PANGASIANODON HYPOPHTHALMUS; PARALICHTHYS OLIVACEUS; PLECOGLOSSUS ALTIVELIS; PLEURONECTOIDEI; SALMO SALAR; SCOPHTHALMIDAE; SCOPHTHALMUS MAXIMUS; SERIOLA DUMERILI; SERIOLA LALANDI; SERIOLA QUINQUERADIATA; SERRANIDAE; SPARUS AURATA; SUIDAE; TILAPIA;

DNA; DNA VACCINE; INACTIVATED VACCINE; LIVE VACCINE;

ANIMAL; ANIMAL DISEASE; AQUACULTURE; EMULSION; FIN FISH; FISH; FISH DISEASE; IMMUNOLOGY; LICENSED VACCINE; LIVE ATTENUATED; REVIEW; VACCINATION;

DNA; EMULSION; FIN FISH; LICENSED VACCINE; LIVE ATTENUATED;

ANIMALS; AQUACULTURE; FISH DISEASES; FISHES; VACCINATION; VACCINES, ATTENUATED; VACCINES, DNA; VACCINES, INACTIVATED;

EID: 84888430455     PISSN: 10504648     EISSN: 10959947     Source Type: Journal    
DOI: 10.1016/j.fsi.2013.05.029     Document Type: Review

References (100)

1. Aucouturier J., Dupuis L., Ganne V. Adjuvants designed for veterinary and human vaccines. Vaccine 2001, 19:2666-2672.
2. Afonso A., Gomes S., da S.J., Marques F., Henrique M. Side effects in sea bass (Dicentrarchus labrax L.) due to intraperitoneal vaccination against vibriosis and pasteurellosis. Fish Shellfish Immunol 2005, 19:1-16.
3. Alexandersen S. Advantages and disadvantages of using live vaccines risks and control measures. Acta Vet Scand Suppl 1996, 90:89-100.
4. Amend D., Johnson K. Current status and future needs of Vibrio anguillarum bacterins. Fish biologics: serodiagnostics and vaccines 1981.
5. Aunsmo A., Valle P.S., Sandberg M., Midtlyng P.J., Bruheim T. Stochastic modelling of direct costs of pancreas disease (PD) in Norwegian farmed Atlantic salmon (Salmo salar L.). Prev Vet Med 2010, 93:233-241.
6. Bebak J., Wagner B. Use of vaccination against enteric septicemia of catfish and columnaris disease by the U.S. catfish industry. JAquatic Anim Health 2012, 24:30-36.
7. Bjornsdottir B., Gudmundsdottir S., Bambir S.H., Magnadottir B., Gudmundsdottir B.K. Experimental infection of turbot, Scophthalmus maximus (L.), by Moritella viscosa, vaccination effort and vaccine-induced side-effects. JFish Dis 2004, 27:645-655.
8. Canadian Food Inspection Agency, 2012. http://active.inspection.gc.ca/scripts/database/vetbio_submit.asp%3flang%3de%26species%3d9%26manufacturer%3dall.
9. Castro N., Toranzo A.E., Nunez S., Magarinos B. Development of an effective Edwardsiella tarda vaccine for cultured turbot (Scophthalmus maximus). Fish Shellfish Immunol 2008, 25:208-212.
10. Clark A., Nowak B. Field investigations of amoebic gill disease in Atlantic salmon, Salmo salar L. JFish Dis 1999, 22:433-443. in Tasmania.
11. Clark T.G., Cassidy-Hanley D. Recombinant subunit vaccines: potentials and constraints. Dev Biol (Basel) 2005, 121:153-163.
12. Corbeil S., LaPatra S.E., Anderson E.D., Kurath G. Nanogram quantities of a DNA vaccine protect rainbow trout fry against heterologous strains of infectious hematopoietic necrosis virus. Vaccine 2000, 18:2817-2824.
13. Cox J.C., Coulter A.R. Adjuvants - a classification and review of their modes of action. Vaccine 1997, 15:248-256.
14. Daly J.G., Griffiths S.G., Kew A.K., Moore A.R., Olivier G. Characterization of attenuated Renibacterium salmoninarum strains and their use as live vaccines. Dis Aquat Organ 2001, 44:121-126.
15. Efeedlink, 2012. http://www.efeedlink.com/contents/08-06-2012/b5276647-458e-45d2-90ff-c51bc6c19eb0-a182.html.
16. Eissler Y., Pavlov S., Conejeros P., Espinoza C., Kuznar J. Detection and quantification of Chilean strains of infectious pancreatic necrosis virus by real-time RT-PCR assays using segment B as a target. Latin Am J Aquatic Res 2011, 39:544-552.
17. European Commision, 2005. http://eur-lex.europa.eu/LexUriServ/site/en/oj/2005/l_030/l_03020050203en00190019.pdf.
18. Evans J.J., Bohnsack J.F., Klesius P.H., Whiting A.A., Garcia J.C., Shoemaker C.A., et al. Phylogenetic relationships among Streptococcus agalactiae isolated from piscine, dolphin, bovine and human sources: a dolphin and piscine lineage associated with a fish epidemic in Kuwait is also associated with human neonatal infections in Japan. JMed Microbiol 2008, 57:1369-1376.
19. Evensen Ø., Brudeseth B., Mutuloki S. The vaccine formulation and its role in inflammatory processes in fish - effects and adverse effects. Progress in fish vaccinology 2005, 117-127. P. Midtlyng (Ed.).
20. FAO Fishery and Aquaculture, 2010. http://www.fao.org/fishery/statistics/en.
21. FAO Fishery and Aquaculture, 2012. http://www.fao.org/fishery/statistics/en.
22. Fisheries and Oceans Canada, 2012. http://www.dfo-mpo.gc.ca/stats/aquaculture-eng.htm.
23. ® IridoV receives first market authorisation in Singapore 2012, http://www.fishupdate.com/news/fullstory.php/aid/18164/AQUAVAC_AE_IridoV_receives_first_market_authorisation_in_Singapore.html.
24. Fiskeridirektoratet 2012, http://www.fiskeridir.no/statistikk/akvakultur/statistikk-for-akvakultur/andre-marine-fiskearter.
25. Fredriksen B.N., Saevareid K., McAuley L., Lane M.E., Bogwald J., Dalmo R.A. Early immune responses in Atlantic salmon (Salmo salar L.) after immunization with PLGA nanoparticles loaded with a model antigen and beta-glucan. Vaccine 2011, 26:8338-8349.
26. Frenkel V., Kimmel E., Iger Y. Ultrasound-induced cavitation damage to external epithelia of fish skin. Ultrasound Med Biol 1999, 25:1295-1303.
27. Frenkel V., Kimmel E., Iger Y. Ultrasound-facilitated transport of silver chloride (AgCl) particles in fish skin. JControl Release 2000, 68:251-261.
28. Frenkel V., Kimmel E., Iger Y. Ultrasound-induced intercellular space widening in fish epidermis. Ultrasound Med Biol 2000, 26:473-480.
29. Frey J. Biological safety concepts of genetically modified live bacterial vaccines. Vaccine 2007, 25:5598-5605.
30. Gravningen K., Johansen L., Nissen B., Rikardsen K., Thorarinsson R., Greger E., et al. Divalent vaccine for sea bass (Dicentrarchus labrax) against vibriosis and pasteurellosis. JAppl Ichthylogy 1998, 14:159-162.
31. Gravningen K., Kestin S., Thorarinsson R., Syvertsen C. Oral vaccination against enteric red mouth disease in rainbow trout (Oncorhynchus mykiss Walbaum). The effect of vaccine dose rate on protection against the disease. JAppl Ichthylogy 1998, 14:163-166.
32. Gravningen K., Sakai M., Mishiba T., Fujimoto T. The efficacy and safety of an oil-based vaccine against Photobacterium damsela subsp. piscicida in yellowtail (Seriola quinqueradiata): a field study. Fish Shellfish Immunol 2008, 24:523-529.
33. Guy B. The perfect mix: recent progress in adjuvant research. Nat Rev Microbiol 2007, 5:505-517.
34. Heads of Medicines Agencies (HMA), 2012. http://mri.medagencies.org/Veterinary/.
35. Heit A., Busch D.H., Wagner H., Schmitz F. Vaccine protocols for enhanced immunogenicity of exogenous antigens. Int J Med Microbiol 2008, 298:27-32.
36. Heit A., Schmitz F., Haas T., Busch D.H., Wagner H. Antigen co-encapsulated with adjuvants efficiently drive protective T cell immunity. Eur J Immunol 2007, 37:2063-2074.
37. Hopkins B.A., Olson L.D. Comparison of live avirulent PM-1 and CU fowl cholera vaccines in turkeys. Avian Dis 1997, 41:317-325.
38. Huising M.O., Guichelaar T., Hoek C., Verburg-van Kemenade B.M., Flik G., Savelkoul H.F., et al. Increased efficacy of immersion vaccination in fish with hyperosmotic pretreatment. Vaccine 2003, 21:4178-4193.
39. Hynes N.A., Furnes C., Fredriksen B.N., Winther T., Bogwald J., Larsen A.N., et al. Immune response of Atlantic salmon to recombinant flagellin. Vaccine 2011, 13:7678-7687.
40. Intervet, 2012. http://aqua.merck-animal-health.com/binaries/AquaVac_Oral_Vacciantion_Guide_tcm127-213884.pdf.
41. Kanchan V., Panda A.K. Interactions of antigen-loaded polylactide particles with macrophages and their correlation with the immune response. Biomaterials 2007, 28:5344-5357.
42. Kang B. Fish vaccine development in Korea 2011, http://www.lib.noaa.gov/retiredsites/korea/diseases/vaccine.html.
43. Katare Y.K., Muthukumaran T., Panda A.K. Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles. Int J Pharmaceutics 2005, 301:149-160.
44. Kileng O., Albuquerque A., Robertsen B. Induction of interferon system genes in Atlantic salmon by the imidazoquinoline S-27609, a ligand for Toll-like receptor 7. Fish Shellfish Immunol 2008, 24:514-522.
45. Kim C.H., Johnson M.C., Drennan J.D., Simon B.E., Thomann E., Leong J.A. DNA vaccines encoding viral glycoproteins induce nonspecific immunity and Mx protein synthesis in fish. JVirol 2000, 74:7048-7054.
46. Klesius P.H., Shoemaker C.A. Development and use of modified live Edwardsiella ictaluri vaccine against enteric septicemia of catfish. Adv Vet Med 1999, 41:523-537.
47. Kontali Salmon world 2012 2012.
48. Kontali seabass & seabream monthly report 2012, http://www.kontali.no/%3fdiv_id%3d73%26pag_id%3d75.
49. Koppang E.O., Bjerkas I., Haugarvoll E., Chan E.K.L., Szabo N.J., Ono N., et al. Vaccination-induced systemic autoimmunity in farmed Atlantic salmon. JImmunol 2008, 181:4807-4814.
50. Lavelle E.C., Jenkins P.G., Harris J.E. Oral immunization of rainbow trout with antigen microencapsulated in poly(DL-lactide-co-glycolide) microparticles. Vaccine 1997, 15:1070-1078.
51. Lee S.W., Markham P.F., Coppo M.J., Legione A.R., Markham J.F., Noormohammadi A.H., et al. Attenuated vaccines can recombine to form virulent field viruses. Science 2012, 337:188.
52. Lorenzen N., LaPatra S.E. DNA vaccines for aquacultured fish. Rev Sci Tech 2005, 24:201-213.
53. Lorenzen N., Lorenzen E., Einer-Jensen K., Heppell J., Davis H.L. Genetic vaccination of rainbow trout against viral haemorrhagic septicaemia virus: small amounts of plasmid DNA protect against a heterologous serotype. Virus Res 1999, 63:19-25.
54. Magnadottir B. Immunological control of fish diseases. Mar Biotechnol (NY) 2010, 12:361-379.
55. Maira C., Lystad Y., Schrøder M.B., Lund V., Gudmundsdottir B. Side effects of injected vaccines in cod - adapting the side-effect scale to cod. Fish Farming Expert 2008, 3:57-61.
56. Maskon, 2012. http://www.maskon.no/pages/vaksine.html.
57. Midtlyng P.J., Reitan L.J., Lillehaug A., Ramstad A. Protection, immune responses and side effects in Atlantic salmon (Salmo salar L) vaccinated against furunculosis by different procedures. Fish Shellfish Immunol 1996, 6:599-613.
58. Midtlyng P.J., Reitan L.J., Speilberg L. Experimental studies on the efficacy and side-effects of intraperitoneal vaccination of Atlantic salmon (Salmo salar L) against furunculosis. Fish Shellfish Immunol 1996, 6:335-350.
59. MSD Animal Health, 2012. http://www.thefishsite.com/focus/msd-animal-health/61/msd-animal-health-aquaculture-norvax-strep-si-warm-water-product-details.
60. Muir J. Managing to harvest? Perspectives on the potential of aquaculture. Philos Trans R Soc Lond B Biol Sci 2005, 360:191-218.
61. Munang'andu H.M., Fredriksen B.N., Mutoloki S., Brudeseth B., Kuo T.Y., Marjara I.S., et al. Comparison of vaccine efficacy for different antigen delivery systems for infectious pancreatic necrosis virus vaccines in Atlantic salmon (Salmo salar L.) in a cohabitation challenge model. Vaccine 2012, 30:4007-4016.
62. Mutoloki S., Alexandersen S., Evensen O. Sequential study of antigen persistence and concomitant inflammatory reactions relative to side-effects and growth of Atlantic salmon (Salmo salar L.) following intraperitoneal injection with oil-adjuvanted vaccines. Fish Shellfish Immunol 2004, 16:633-644.
63. Mutoloki S., Cooper G.A., Marjara I.S., Koop B.F., Evensen O. High gene expression of inflammatory markers and IL-17A correlates with severity of injection site reactions of Atlantic salmon vaccinated with oil-adjuvanted vaccines. BMC Genomics 2010, 11.
64. Mutoloki S., Reite O.B., Brudeseth B., Tverdal A., Evensen O. Acomparative immunopathological study of injection site reactions in salmonids following intraperitoneal injection with oil-adjuvanted vaccines. Vaccine 2006, 24:578-588.
65. Nakajima K., Maeno Y., Honda A., Yokoyama K., Tooriyama T., Manabe S. Effectiveness of a vaccine against red sea bream iridoviral disease in a field trial test. Dis Aquat Organ 1999, 36:73-75.
66. Nakajima N. Fish vaccines in Japan 2011, http://www.srr-seasia-oie.com/fileadmin/damRoot/HPED/Document/15._OIE_Fish_vaccines_cambodia_FINAL.pdf.
67. Nakanishi T., Kiryu I., Ototake M. Development of a new vaccine delivery method for fish: percutaneous administration by immersion with application of a multiple puncture instrument. Vaccine 2002, 20:3764-3769.
68. Newman S. Bacterial vaccines of fish. Annu Rev Fish Dis 1993, 3:145-186.
69. Nisseken Vaccine Oceantect VNN (Inactivated vaccine for viral nervous necrosis in sevenband grouper) 2012, http://www.jp-nisseiken.co.jp/en/products/vaccine/index.html#anc07.
70. NorVacc, 2012. http://www.norvacc.com/vaccination-of-fish-2.
71. Palti Y. Toll-like receptors in bony fish: from genomics to function. Dev Comp Immunol 2011, 35:1263-1272.
72. Park S. Disease control in Korean aquaculture. Fish Pathol 2009, 44:19-23.
73. PHARMAQ, 2012. http://pharmaq.no/sfiles/1/23/2/file/vaccines_norway_2012-08_no.pdf.
74. Pridgeon J.W., Klesius P.H. Virulence of Aeromonas hydrophila to channel catfish Ictaluras punctatus fingerlings in the presence and absence of bacterial extracellular products. Dis Aquat Organ 2011, 95:209-215.
75. Salonius K., Siderakis C., MacKinnon A.M., Griffiths S.G. Use of Arthrobacter davidanieli as a live vaccine against Renibacterium salmoninarum and Piscirickettsia salmonis in salmonids. Dev Biol (Basel) 2005, 121:189-197.
76. Schijns V., Tangerås A. Vaccine adjuvant technology: from theoretical mechanisms to practical approaches. Dev Biol (Basel) 2005, 121:127-134.
77. Schlosser E., Mueller M., Fischer S., Basta S., Busch D.H., Gander B., et al. TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses. Vaccine 2008, 26:1626-1637.
78. Shoemaker C., Klesius P., Bricker J. Efficacy of a modified live Edwardsiella ictaluri vaccine in channel catfish as young as seven days post hatch. Aquaculture 1999, 176:189-193.
79. Simard N, Bootland L. IHNV G protein for immune stimulation; 2007 US Patent 7501128, European patent EP1553979.
80. Slotved H.C., Kong F., Lambertsen L., Sauer S., Gilbert G.L. Serotype IX, a proposed new Streptococcus agalactiae serotype. JClin Microbiol 2007, 45:2929-2936.
81. Sommerset I., Krossoy B., Biering E., Frost P. Vaccines for fish in aquaculture. Expert Rev Vaccines 2005, 4:89-101.
82. Stewart A.J., Devlin P.M. The history of the smallpox vaccine. JInfect 2006, 52:329-334.
83. Strandskog G., Villoing S., Iliev D.B., Thim H.L., Christie K.E., Jorgensen J.B. Formulations combining CpG containing oliogonucleotides and poly I: C enhance the magnitude of immune responses and protection against pancreas disease in Atlantic salmon. Dev Comp Immunol 2011, 35:1116-1127.
84. Ström-Bestor M., Mustamaki N., Heinikainen S., Hirvela-Koski V., Werner-Jeffreys D., Wiklund T. Introduction of Yersinia ruckeri biotype 2 into Finnish fish farms. Aquaculture 2012, 308:1-5.
85. Suanyuka N., Kongb F., Kob D., Gilbert G., Supamattayaa K. Occurence of rare genotypres of Streptococcus agalactiae in cultured red tilapia Oreochromis sp. and Nile ttilapia O.niloticus in Thailand - relationship to human isolates? 2008, 35-40.
86. Tanrikul T.T. Vibriosis as an epizootic disease of rainbow trout (Onchorynchus mykiss) in Turkey. Pak J Biol Sci 2007, 10:1733-1737.
87. Tatner M.F. The ontogeny of humoral immunity in rainbow trout, Salmo gairdneri. Vet Immunol Immunopathol 1986, 12:93-105.
88. Thanh P., Berntsen J. Towards sustainability: vaccinated pangasius in Vietnam 2012, http://www.pharmaq.no/sfiles/7/55/1/file/pharmaq-pages-from-aq12058_aqua_may12-final-lr-5.pdf.
89. Thim H.L., Iliev D.B., Christie K.E., Villoing S., McLoughlin M.F., Strandskog G., et al. Immunoprotective activity of a salmonid alphavirus vaccine: comparison of the immune responses induced by inactivated whole virus antigen formulations based on CpG class B oligonucleotides and poly I: C alone or combined with an oil adjuvant. Vaccine 2012, 30:4828-4834.
90. Thune R., Plumb J. Evaluation of hyperosmotic infiltration for the administration of antigen to channel catfish (Ictalurus punctatus). Aquaculture 1984, 36:8-44.
91. Tian J., Yu J., Sun X. Chitosan microspheres as candidate plasmid vaccine carrier for oral immunisation of Japanese flounder (Paralichthys olivaceus). Vet Immunol Immunopathol 2008, 126:220-229.
92. Tian J.Y., Sun X.Q., Chen X.G. Formation and oral administration of alginate microspheres loaded with pDNA coding for lymphocystis disease virus (LCDV) to Japanese flounder. Fish Shellfish Immunol 2008, 24:592-599.
93. Toranzo A.E., Santos Y., Barja J.L. Immunization with bacterial antigens: vibrio infections. Dev Biol Stand 1997, 90:93-105.
94. Toranzo A., Barja J. Areview of the taxonomy and seroepizootiology of Vibrio anguillarum, with special reference to aquaculture in the northwest of Spain. Dis Aquat Organ 1990, 9:73-82.
95. Toranzo A., Romalde B., Magarinos B., Barja J. Present and future of aquaculture vaccines against fish bacterial diseases. Options mediterraneennes A - the use of veterinary drugs vaccines mediterranean aquaculture 2009, 86.
96. United States Departament of Agriculture (USDA) E.S.a.M.I.S, 2012. http://usda.mannlib.cornell.edu/MannUsda/viewDocumentInfo.do%3fdocumentID%3d1172.
97. Vandamme P., Devriese L.A., Pot B., Kersters K., Melin P. Streptococcus difficile is a nonhemolytic group B, type Ib Streptococcus. Int J Syst Bacteriol 1997, 47:81-85.
98. Wendover N. Diseases of farmed barramundi in Asia 2012, http://www.thefishsite.com/articles/1086/diseases-of-farmed-barramundi-in-asia.
99. Yang X., Cao H. Progress on fish disease research in China. Aquaculture research trends 2008, 13-57. S.H. Schwartz (Ed.).
100. Zeman D., Neiger R., Nietfield J., Miskimins D., Libal M., Johnson D., et al. Systemic Pasteurella haemolytica infection as a rare sequel to avirulent live Pasteurella haemolytica vaccination in cattle. JVet Diagn Invest 1993, 5:555-559.